510(k) K232991
K232991 is an FDA 510(k) premarket notification submitted by Bistos Co., Ltd. for the device "BT-1000". The FDA issued a decision of Substantially Equivalent on Aug 28, 2024. The device falls under product code QGL (Transcutaneous Nerve Stimulator For Adhd), a Class II device regulated under 21 CFR 882.5898. Bistos Co., Ltd. has 10 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 28, 2024
- Date Received
- Sep 22, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Transcutaneous Nerve Stimulator For Adhd
- Device Class
- Class II
- Regulation Number
- 882.5898
- Review Panel
- NE
- Submission Type
- 510(k)
A transcutaneous electrical nerve stimulator for Attention Deficit Hyperactivity Disorder (ADHD) is a prescription device that stimulates transcutaneously or percutaneously through electrodes placed on the forehead.
Need the full FDA record for Bistos Co., Ltd.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.